Clinical Trials

30 enrolled

Plasma cell

Multiple Myeloma

NCT03646123 2025-08-28

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Phase 2 Terminated

255 enrolled 29 charts

Hodgkin Disease

NCT04345900 2024-05-16

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

55 enrolled 21 charts

Chemotherapy-induced Neutropenia

NCT02104427 2021-04-19

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

12 enrolled 10 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT01753453 2021-02-23

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

23 enrolled

Plasma cell

Multiple Myeloma

NCT00211185 2020-03-18

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

49 enrolled 11 charts

Lymphoma, T-Cell, Peripheral

NCT01025284 2019-09-17

A Study for Participants With Small-Cell Lung Cancer

64 enrolled 18 charts

Thoracic

Small Cell Lung Carcinoma

NCT02282215 2018-09-27

Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

Other hematologic neoplasm

163 enrolled

Fever, Infections, Leukemia, Neutropenia, Leukemia, Myeloid, Acute

NCT00395967 2015-05-01

AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

Phase 2 Terminated

5 enrolled 8 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT01923545 2014-10-01

PEG-G-CSF

61 enrolled

Chemotherapy Induced Neutropenia

NCT00322387 2014-03-13

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

40 enrolled 10 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00322491 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

49 enrolled 13 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00322842 2014-03-13

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

35 enrolled 13 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00396201 2014-03-13

AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease

22 enrolled 17 charts

Hodgkin Disease

NCT00396331 2014-03-13

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

100 enrolled 23 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00444912 2014-03-13

The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)

30 enrolled 20 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT00396266 2014-03-07

AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

22 enrolled 16 charts